Istituto Nazionale Per Le Malattie
Infettive Lazzaro Spallanzani
I.R.C.C.S.

CAGE Code: AK572

NCAGE Code: AK572

Status: Active

Type: Commercial Supplier

Summary

Istituto Nazionale Per Le Malattie, Infettive Lazzaro Spallanzani, I.R.C.C.S. is an Active Commercial Supplier with the Cage Code AK572.

Address

Via Portuense 292
Roma
Roma
00149
Italy

Points of Contact

No Points of Contact...

Related Information

No Related Information...

Associated CAGE Codes People who viewed this 'CAGE Code' also viewed...

CAGE Code FAQ Frequently Asked Questions (FAQ) for CAGE AK572

What is CAGE Code AK572?
AK572 is the unique identifier used by NATO Organizations to reference the physical entity known as Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani I.R.C.C.S. located at Via Portuense 292, Roma, Roma, 00149, Italy.
Who is CAGE Code AK572?
AK572 refers to Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani I.R.C.C.S. located at Via Portuense 292, Roma, Roma, 00149, Italy.
Where is CAGE Code AK572 Located?
CAGE Code AK572 is located in Roma, Italy.

Contracting History for CAGE AK572 Contracting History for CAGE AK572 Most Recent 25 Records

HHSF223201510111C
Igf::Cl::Igf Baa Contract Titled, "Field Validation Of Bsl-2 Assays To Diagnose Total And Neutralizing Anti-Ebola Antibodies In West Africa."
1 Sep 2015
Dept Of Hhs/Food And Drug Administration
Department Of Health And Human Services (Hhs)
$255,460.14
HHSF223201510111C
Igf::Cl::Igf Baa Contract Titled, "Field Validation Of Bsl-2 Assays To Diagnose Total And Neutralizing Anti-Ebola Antibodies In West Africa."
5 Jul 2017
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$310,000.00
HHSF223201510111C
Igf::Cl::Igf Baa Contract Titled, "Field Validation Of Bsl-2 Assays To Diagnose Total And Neutralizing Anti-Ebola Antibodies In West Africa."
9 May 2018
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$310,000.00
HHSF223201510111C
Igf::Cl::Igf Baa Contract Titled, "Field Validation Of Bsl-2 Assays To Diagnose Total And Neutralizing Anti-Ebola Antibodies In West Africa."
27 Jan 2017
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$310,000.00
HHSF223201510111C
Igf Cl Igf Baa Contract Titled, "Field Validation Of Bsl-2 Assays To Diagnose Total And Neutralizing Anti-Ebola Antibodies In West Africa."
25 Feb 2022
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$255,460.14